News on Taiho Yakuhin from BioPortfolio.com http://www.BioPortfolio.com Consolidated Taiho Yakuhin news from BioPortfolio.com Wed, 10 Feb 2010 09:22:41 GMT en Taiho Pharmaceutical Co., Ltd.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016139&HITNO=0&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016139&THISHREF=http://c.moreover.com/click/here.pl%3fz2524648854%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016139&HITNO=0&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016139&THISHREF=http://c.moreover.com/click/here.pl%3fz2524648854%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Oncology: Palonosetron Approved In Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950180&HITNO=1&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950180&THISHREF=http://c.moreover.com/click/here.pl%3fz2489509156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950180&HITNO=1&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950180&THISHREF=http://c.moreover.com/click/here.pl%3fz2489509156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Batch of Japanese drug approvals, including for Taiho, Daiichi Sankyo and three for Novartishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940107&HITNO=2&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940107&THISHREF=http://c.moreover.com/click/here.pl%3fz2484934119%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940107&HITNO=2&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940107&THISHREF=http://c.moreover.com/click/here.pl%3fz2484934119%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Letter: Oncology: Palonosetron Approved In Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935008&HITNO=3&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935008&THISHREF=http://c.moreover.com/click/here.pl%3fz2482463582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935008&HITNO=3&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935008&THISHREF=http://c.moreover.com/click/here.pl%3fz2482463582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Oncology: Palonosetron Approved in Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934150&HITNO=4&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934150&THISHREF=http://c.moreover.com/click/here.pl%3fz2482075995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934150&HITNO=4&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934150&THISHREF=http://c.moreover.com/click/here.pl%3fz2482075995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: Oncology: Palonosetron Approved in Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934131&HITNO=5&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934131&THISHREF=http://c.moreover.com/click/here.pl%3fz2482066611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934131&HITNO=5&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934131&THISHREF=http://c.moreover.com/click/here.pl%3fz2482066611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Oncology: Palonosetron Approved in Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933797&HITNO=6&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933797&THISHREF=http://c.moreover.com/click/here.pl%3fz2481929018%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933797&HITNO=6&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933797&THISHREF=http://c.moreover.com/click/here.pl%3fz2481929018%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: Taiho Pharmaceutical Co., Ltd.: Oncology: Palonosetron Approved In Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935541&HITNO=7&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935541&THISHREF=http://c.moreover.com/click/here.pl%3fz2482654717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3935541&HITNO=7&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3935541&THISHREF=http://c.moreover.com/click/here.pl%3fz2482654717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Oncology: Palonosetron Approved in Japan, Second Pharmaceutical Market Worldwidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933990&HITNO=8&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933990&THISHREF=http://c.moreover.com/click/here.pl%3fz2482018345%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933990&HITNO=8&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933990&THISHREF=http://c.moreover.com/click/here.pl%3fz2482018345%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: MethylGene to Present at Biotech Showcase 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3882071&HITNO=9&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3882071&THISHREF=http://c.moreover.com/click/here.pl%3fz2454289085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3882071&HITNO=9&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3882071&THISHREF=http://c.moreover.com/click/here.pl%3fz2454289085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR-USA.net: MethylGene to Present at Biotech Showcase 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870907&HITNO=10&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870907&THISHREF=http://c.moreover.com/click/here.pl%3fz2448968688%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870907&HITNO=10&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870907&THISHREF=http://c.moreover.com/click/here.pl%3fz2448968688%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: MethylGene to Present at Biotech Showcase 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870905&HITNO=11&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870905&THISHREF=http://c.moreover.com/click/here.pl%3fz2448968300%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870905&HITNO=11&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870905&THISHREF=http://c.moreover.com/click/here.pl%3fz2448968300%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: MethylGene to Present at Biotech Showcase 2010 - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870785&HITNO=12&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870785&THISHREF=http://c.moreover.com/click/here.pl%3fz2448926917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870785&HITNO=12&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870785&THISHREF=http://c.moreover.com/click/here.pl%3fz2448926917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: GlaxoSmithKline's Duodart Will Become Decision Resources' New Clinical Gold Standard by 2013 for the Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870695&HITNO=13&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870695&THISHREF=http://c.moreover.com/click/here.pl%3fz2448888024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870695&HITNO=13&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870695&THISHREF=http://c.moreover.com/click/here.pl%3fz2448888024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: MethylGene to Present at Biotech Showcase 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870649&HITNO=14&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870649&THISHREF=http://c.moreover.com/click/here.pl%3fz2448877355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3870649&HITNO=14&MSIZE=31&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taiho%20Yakuhin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3870649&THISHREF=http://c.moreover.com/click/here.pl%3fz2448877355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: